Sørensen et al. (1) report that in Norway, low concentration of 25-hydroxy-vitamin D [25(OH)D] in mothers during pregnancy was associated with an increased risk of type 1 diabetes in the offspring. We would like to point out that one putative confounding factor in their study might have been the intake of n-3 polyunsaturated fatty acids. Childhood n-3 fatty acid intake and status have been linked with the development of pretype 1 diabetes (2), while reasonably powered prospective studies of exposure during pregnancy are lacking. Of pregnant Norwegian women, 59% used cod liver or fish oil during pregnancy during the years 2002–2005 (3). In the study by Sørensen et al. (1), the samples were collected in 1992–1994. Cod liver oil contains both vitamin D and n-3 polyunsaturated fatty acids. Serum levels of 25(OH)D are likely to correlate with the intake of n-3 polyunsaturated fatty acids in a situation where the dietary sources of vitamin D and n-3 fatty acids are—to a large extent—the same.

A recently published Finnish study (4) with the similar nested case-control design did not find an association between maternal 25(OH)D concentration and the risk of type 1 diabetes in the offspring. In the study by Miettinen et al. (4), samples were collected in 1993–2000. Unlike in Norway, less than 2% of Finnish pregnant women consumed cod liver or fish oil supplements, whereas 30% of the women used other vitamin D containing supplements (5).

Another important difference is the much lower mean concentration of 25(OH)D during pregnancy in Finland than in Norway (1,4). About 70% of the Finnish mothers had vitamin D insufficiency or deficiency [25(OH)D <50 nmol/L], which may have lead to difficulties to discern any differences between the groups. Low serum levels of 25(OH)D in Finnish pregnant women reflect the low vitamin D intake. Mean maternal daily intake of vitamin D from diet was 5.1 μg and from supplements was 1.3 μg in Finland during the years 1997–2002 (5), whereas respective intakes were 3.5 μg and 10.1 μg in Norway (3). Possible other explanations for the different findings between the studies (1,4) include the fact that the samples were collected mainly during the last trimester of pregnancy in Norway, and during the first trimester in Finland.

No potential conflicts of interest relevant to this article were reported.

1.
Sørensen
IM
,
Joner
G
,
Jenum
PA
,
Eskild
A
,
Torjesen
PA
,
Stene
LC
.
Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type 1 diabetes in the offspring
.
Diabetes
2012
;
61
:
175
178
2.
Norris
JM
,
Yin
X
,
Lamb
MM
, et al
.
Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes
.
JAMA
2007
;
298
:
1420
1428
3.
Haugen
M
,
Brantsaeter
AL
,
Alexander
J
,
Meltzer
HM
.
Dietary supplements contribute substantially to the total nutrient intake in pregnant Norwegian women
.
Ann Nutr Metab
2008
;
52
:
272
280
4.
Miettinen
ME
,
Reinert
L
,
Kinnunen
L
, et al
.
Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring
.
Diabetologia
2012
;
55
:
1291
1294
5.
Marjamäki
L
,
Niinistö
S
,
Kenward
MG
, et al
.
Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring
.
Diabetologia
2010
;
53
:
1599
1607
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.